Biotechnology Assets SA
MAD:BST

Watchlist Manager
Biotechnology Assets SA Logo
Biotechnology Assets SA
MAD:BST
Watchlist
Price: 0.226 EUR -2.59% Market Closed
Market Cap: 16.5m EUR

Operating Margin
Biotechnology Assets SA

-45.8%
Current
-7%
Average
-4.2%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-45.8%
=
Operating Profit
-1.2m
/
Revenue
2.6m

Operating Margin Across Competitors

No Stocks Found

Biotechnology Assets SA
Glance View

Market Cap
15.4m EUR
Industry
Biotechnology

Biotechnology Assets SA operates as a biopharmaceutical company. The company is headquartered in Jerez De La Frontera, Cadiz and currently employs 32 full-time employees. The company went IPO on 2011-06-14. The Firm’s main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The Company, through its subsidiaries, is also present in Luxembourg, Hong Kong and USA.

BST Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-45.8%
=
Operating Profit
-1.2m
/
Revenue
2.6m
What is the Operating Margin of Biotechnology Assets SA?

Based on Biotechnology Assets SA's most recent financial statements, the company has Operating Margin of -45.8%.

Back to Top